Aegros Strengthens Board with Appointment Of Dr Paul MacLeman as Non-Executive Director
4th May 2026 Aegros has appointed Dr Paul MacLeman BVSc MBA GAICD to its Board as a Non-Executive Director, bringing deep expertise in biopharmaceutical development, finance, ASX-listed company governance, and specialty biologics commercialisation. Dr MacLeman’s career spans executive leadership across multiple ASX, CSE and NASDAQ listed and private life sciences companies. He served as SVP […]
